Overexpression of Romo1 Is an Unfavorable Prognostic Biomarker and a Predictor of Lymphatic Metastasis in Non-Small Cell Lung Cancer Patients

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s161587
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Use of Cell Free DNA as a Prognostic Biomarker in Non-Small Cell Lung Cancer Patients With Bone Metastasis

International Journal of Biological Markers
OncologyCancer ResearchClinical BiochemistryForensic MedicineMedicinePathology
2019English

CPSF3 Is a Promising Prognostic Biomarker and Predicts Recurrence of Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Prognostic Significance of Sites of Extrathoracic Metastasis in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Myc Is a Metastasis Gene for Non-Small-Cell Lung Cancer

PLoS ONE
Multidisciplinary
2009English

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

BAP1 Is a Good Prognostic Factor in Advanced Non-Small Cell Lung Cancer

Clinical and Investigative Medicine
Medicine
2012English

FGFR Genes Mutation Is an Independent Prognostic Factor and Associated With Lymph Node Metastasis in Squamous Non-Small Cell Lung Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

Overexpression of OCT4 Is Associated With Gefitinib Resistance in Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Overexpression of WDR79 in Non-Small Cell Lung Cancer Is Linked to Tumour Progression

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy